« Boyden Starts a Neurotech Blog |
| Economic Burden of Chronic Diseases Report Released »
Posted by Zack Lynch
NERV, the Nasdaq NeuroInsights Neurotech Index was launched last week and is now live. NIO and NeuroInsights hosted a media tour in NYC for several executives from Neurotech index companies including, Uli Hacksell, CEO of ACADIA Pharmaceuticals; Jim Brown, CEO of DURECT Corporation; Ron Cohen, CEO of Acorda Therapeutics; Elliot Ehrich, CMO of Alkermes; and David Hung, CEO of Medivation. Casey and I and the executives traveled to Forbes where we met met with Bob Langreth and Matt Herper at Forbes, five reporters at the Wall Street Journal and the editorial team at Scientific American Mind. To track NERV I recommend going to Nasdaq.com or Yahoo Finance and type in ^NERV(the ^ symbol is used for indices).
+ TrackBacks (0) | Category: NERV - Neurotech Index
1. Andy Lautin on November 9, 2007 9:26 PM writes...
This struck a nerve!
No knee jerk reaction re: NERV, but I'd keep an open mind before I would invest.
A decision to invest in NERV is not a black and white issue because there are so many shades of gray.
This is (or is not) spinal tap?
EMAIL THIS ENTRY TO A FRIEND
About Us |
Contact Us |
© Copyright 2006 Corante. All rights reserved. ()